TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis

Jinchao Hou, Jue Zhang, Ping Cui, Yingyue Zhou, Can Liu, Xiaoliang Wu, Yun Ji, Sicong Wang, Baoli Cheng, Hui Ye, Liqi Shu, Kai Zhang, Di Wang, Jielin Xu, Qiang Shu, Marco Colonna, Xiangming FangJournal of Clinical Investigation 2021 · DOI

Abstract

Sepsis is a leading cause of death in critical illness, and its pathophysiology varies depending on preexisting medical conditions. Here we identified nonalcoholic fatty liver disease (NAFLD) as an independent risk factor for sepsis in a large clinical cohort and showed a link between mortality in NAFLD-associated sepsis and hepatic mitochondrial and energetic metabolism dysfunction. Using in vivo and in vitro models of liver lipid overload, we discovered a metabolic coordination between hepatocyte mitochondria and liver macrophages that express triggering receptor expressed on myeloid cells-2 (TREM2). Trem2-deficient macrophages released exosomes that impaired hepatocytic mitochondrial structure and energy supply because of their high content of miR-106b-5p, which blocks Mitofusin 2 (Mfn2). In a mouse model of NAFLD-associated sepsis, TREM2 deficiency accelerated the initial progression of NAFLD and subsequent susceptibility to sepsis. Conversely, overexpression of TREM2 in liver macrophages improved hepatic energy supply and sepsis outcome. This study demonstrates that NAFLD is a risk factor for sepsis, providing a basis for precision treatment, and identifies hepatocyte-macrophage metabolic coordination and TREM2 as potential targets for future clinical trials.

Introduction

Sepsis remains a primary driver of mortality in intensive care units worldwide. While the systemic inflammatory response is well-characterized, the influence of chronic comorbidities on sepsis outcomes is increasingly recognized as a critical factor for personalized medicine. Nonalcoholic fatty liver disease (NAFLD), the most prevalent chronic liver condition globally, has long been suspected of exacerbating sepsis, but the underlying mechanisms and clinical independence of this risk have remained elusive. This study identifies NAFLD as a major independent risk factor for sepsis mortality and elucidates a novel metabolic "cross-talk" between liver macrophages and hepatocytes mediated by the protein TREM2.

NAFLD as an Independent Sepsis Risk Factor

To investigate the clinical impact of NAFLD, researchers conducted a prospective study of 1,307 septic patients. Using CT-based liver attenuation measurements to objectively diagnose NAFLD, the team found that patients with fatty livers faced significantly higher mortality rates. Crucially, multivariate analysis revealed that NAFLD is an independent predictor of death, even after adjusting for age, sex, BMI, and diabetes.

Adjusted odds ratio for mortality in septic patients with NAFLD across various subgroups, highlighting it as an independent risk factor.

The data showed that the risk was particularly pronounced in certain subgroups, such as those with a lower BMI, suggesting that the metabolic state of the liver itself, rather than just general obesity, is the primary driver of poor outcomes. Patients with NAFLD were found to be nearly three times more likely to die from sepsis across the entire cohort.

The TREM2-Exosome-Mitochondria Axis

The study's mechanistic core centers on TREM2 (triggering receptor expressed on myeloid cells-2), a protein expressed on liver macrophages (Kupffer cells). The researchers discovered that TREM2+ macrophages act as metabolic guardians. In a healthy or compensated state, these cells maintain hepatocyte mitochondrial health through intercellular signaling.

However, in the absence of TREM2—or during the progression of NAFLD—this coordination fails. Trem2-deficient macrophages were found to release an increased volume of extracellular vesicles (exosomes) enriched with miR-106b-5p. This specific microRNA targets and silences Mitofusin 2 (Mfn2) in hepatocytes. Mfn2 is essential for mitochondrial fusion; its loss leads to mitochondrial fragmentation and a subsequent failure in fatty acid oxidation (FAO). During sepsis, when the body requires the liver to efficiently process fats for energy, this "energy crisis" leads to organ failure.

Key Clinical and Experimental Outcomes

The clinical data reflected a stark difference in survival: 28-day mortality was 32.56% for NAFLD patients compared to 15.7% for those without. These findings were mirrored in animal models, where overexpressing TREM2 in liver macrophages provided significant protection against sepsis-induced death and improved hepatic ATP production.

28-day survival and hospital mortality rates comparing NAFLD and non-NAFLD septic patients.

Conclusion and Future Directions

This research establishes NAFLD as a "silent" multiplier of sepsis risk and identifies the TREM2-Mfn2 pathway as a vital link in liver-immune metabolic coordination. While the study provides a robust framework for understanding NAFLD-associated sepsis, future work must address the challenges of translating these findings into human therapies, particularly in developing methods to target TREM2 or miR-106b-5p during the acute phase of sepsis. Nevertheless, these insights offer a promising foundation for precision treatments in critically ill patients with underlying liver disease.

Summary updated

Abstract

Sepsis is a leading cause of death in critical illness, and its pathophysiology varies depending on preexisting medical conditions. Here we identified nonalcoholic fatty liver disease (NAFLD) as an independent risk factor for sepsis in a large clinical cohort and showed a link between mortality in NAFLD-associated sepsis and hepatic mitochondrial and energetic metabolism dysfunction. Using in vivo and in vitro models of liver lipid overload, we discovered a metabolic coordination between hepatocyte mitochondria and liver macrophages that express triggering receptor expressed on myeloid cells-2 (TREM2). Trem2-deficient macrophages released exosomes that impaired hepatocytic mitochondrial structure and energy supply because of their high content of miR-106b-5p, which blocks Mitofusin 2 (Mfn2). In a mouse model of NAFLD-associated sepsis, TREM2 deficiency accelerated the initial progression of NAFLD and subsequent susceptibility to sepsis. Conversely, overexpression of TREM2 in liver macrophages improved hepatic energy supply and sepsis outcome. This study demonstrates that NAFLD is a risk factor for sepsis, providing a basis for precision treatment, and identifies hepatocyte-macrophage metabolic coordination and TREM2 as potential targets for future clinical trials.
BibTeX
@article{hou2021trem,
  author = {Jinchao Hou and Jue Zhang and Ping Cui and Yingyue Zhou and Can Liu and Xiaoliang Wu and Yun Ji and Sicong Wang and Baoli Cheng and Hui Ye and Liqi Shu and Kai Zhang and Di Wang and Jielin Xu and Qiang Shu and Marco Colonna and Xiangming Fang},
  title = {{TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis}},
  journal = {Journal of Clinical Investigation},
  year = {2021},
  doi = {10.1172/jci135197},
}
Figure